Navigation Links
Urodynamics Infusion Tubing Set

ProductsUrodynamics Infusion Tubing Set
Company Cook Urological
Item Urodynamics Infusion Tubing Set
Features 
  • For use with Laborie Medical Technologies infusion pumps.
  • Supplied sterile in peel-open packages.
Description Used to connect an infusion bag to an infusion pump, and then to a urodynamics catheter in order to conduct urodynamics studies. For use with Laborie Medical Technologies infusion pumps. Supplied sterile in peel-open packages. Intended for one-time use.
Info Cook Urological
Customer Service: (800) 457-4448
Web site: http://www.cookurological.com/

Related medicine products :

1. OM-5 Lite Urodynamics System
2. OM-5 Lite Urodynamics System with EMG
3. OM-5 Lite Urodynamics System with CO2
4. OM™-5 Plus Urodynamics System with EMG and CO2
5. OM-5 Plus Urodynamics System
6. OM-5 Elite Urodynamics System with EMG
7. TRITON™ Wireless Urodynamics Systems with optional video
8. OM-5 Elite Urodynamics System with EMG and CO2
9. Dorado™ Urodynamics System
10. Solenette™ Wireless Urodynamics Systems
11. Aquarius™ TT Urodynamics Systems with optional video
Cannulated Interference Screws
IEC-Innovative Endoscopy Components, LLC offers high quality Arthroscopy Medical Equipment "Made in Germany". All our Arthroscopes are manufactured according to ISO 9001 standards, featuring the most
The New Digital Recording System From Luxtec,The new MicroLux Digital Video Recorder gives you an entirely new way to visualize, edit, share and store your surgical cases.
...ition is achieved using an increased tilt angle of.... The patient preparation can be carried out outsi...patient can be brought rapidly outside the shielde...ated neck support increases patient safety and com...
Medicine Products:
(Date:5/16/2008)...kard, from Griffiths School of Nursing and Midwife...the HESTA Australian Nursing Awards. , Professo...patient blood loss during testing procedures, redu...ansfusions among already ill patients. The award w...rnes Crown Entertainment complex. , Nurses rout...
(Date:5/16/2008)...on Public Service Announcement Available, RADNOR,...ition of,National Mental Health Month and Older Pe...n Council (SPC) will offer an important message to...ment. The public service,announcement developed by...o the public health problem of depression and to o...
(Date:5/16/2008)... appointment of Nomura Code Securities Limited as ...r, NEW YORK, May 16 /PRNewswire-FirstCall/ -- Med...ts, Inc. (Amex: MGT ) (the "Company"), and an,ind...Detection (CAD) and,image analysis software which ...sease, today announced the appointment of NM Roths...
(Date:5/16/2008)...16 /PRNewswire/ -- Barbara Senich, B.S.N., M.B.A.,... Services, was honored by,Executive Women of New J...2008 Awards Dinner. The biennial event, held May 1...ized women of professional distinction in New,Jers...of directors at major,New Jersey-based corporation...
Breaking Medicine News(10 mins):Health News:Research talent wins national Innovation in Nursing award 2Health News:Suicide Prevention Group Delivers Much-Needed Message to Pennsylvania's Elderly 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 3Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 2Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 3
...ident, Dr Mukesh Haikerwal, today urged all Austra...eir families about their desire to donate organs./... of Australia has revealed that organs for transpl... a fraction of the nation’s potential donors. The...
...(R) in PEPCHF Trial, has been the first agent to d...ure patients with diastolic dysfunction.// The dr...s toelderly people with chronic heart failure acco...CE inhibitor Coversyl(R) that was presented at the...
...ortunities for organ donation are being missed in ...on rates that are among the lowest in the Western ...test edition of the Medical Journal of Australia (...lvester, Intensive Care Specialists at Austin Heal...
... bracing itself for an outbreak of the deadly bird...and Sohaj governorates.// The first of these cases... Sohag province, some 490 kilometers or 305 miles ...ng this report all poultry on the farm were slaugh...
Other Medicine News:Health News:AMA Urges Organ Donors to Speak Up 2Health News:Coversyl Demonstrates Clinical Benefits in Elderly Patients 2Health News:Lost Opportunities for Organ Donation 2
(Date:5/15/2008)...5 /- Ergonex Pharma today,announced t... (FDA) has,granted orphan drug designation to Terg...rtension (PAH). Terguride is currently being evalu...., "The FDA,s grant of orphan drug designation to...development program by offering regulatory,clinic...
(Date:5/15/2008).../- Tigris Pharmaceuticals,Inc. annou... and,Development Agreement (CRADA) with the Nation...al and preclinical development of AFP-464, an,amin... is converted to,metabolites which bind covalently...., This is part of a four-year CRADA encompassing...
(Date:5/15/2008)...for an Antiplatelet Therapy that, Combined, with A...of Plavix/Iscover and Aspirin, According to a ...., May 15 /- Decision Resources, one ... for pharmaceutical and,healthcare issues, finds t...ovement in patient compared to Sanofi-Aventis/Bris...
(Date:5/15/2008)...er CEA Trial data reports in third quarter ...15 /- VIA Pharmaceuticals,...used on the development of,compounds for the treat...at,it has completed patient enrollment in its acut...one of three Phase 2 trials investigating VIA-2291...
Breaking Medicine Technology:Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 1Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 2Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 3Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 4Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 5Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2180 1Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2180 2Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2180 3Anesiva Raises 2445 Million in Common Stock Offering 2178 1Anesiva Raises 2445 Million in Common Stock Offering 2178 2Cell Therapeutics Inc Announces Issuance of 2423 25 Million in New Convertible Senior Notes in Exchange for 2436 08 Million of Existing Convertibl 2175 1Cell Therapeutics Inc Announces Issuance of 2423 25 Million in New Convertible Senior Notes in Exchange for 2436 08 Million of Existing Convertibl 2175 2Cell Therapeutics Inc Announces Issuance of 2423 25 Million in New Convertible Senior Notes in Exchange for 2436 08 Million of Existing Convertibl 2175 3
...ly 9, 2007 - NexMed, Inc.,(NASDAQ: NEXM), a develo...the NexACT(R) drug delivery technology, today anno...t enrollment for Phase,III clinical trials for NM1... fungus). Pursuant to the terms of the licensing,a... a milestone,payment early next year. NexMed enter...
... 2007 - Neurologix, Inc.,(OTCBB:NRGX), a biotechno...ive gene therapies for the brain and central nervo...resent at the Third Annual,C.E. Unterberg Towbin E... at 4:30 pm ET at The Mandarin Oriental Hotel in N...hn Mordock will discuss,Neurologix,s business and ...
Other Medicine Technology:NexMed Announces Completion of Patient Enrollment in Two Pivotal,Phase 3 Studies for Anti-Fungal Product 2